Nanobiotechnology-based treatment strategies for malignant relapsed glioma
Authors:
- 25 May 2023
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 358, 681-705
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573616, 81690263, 81773911)
This publication has 289 references indexed in Scilit:
- High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole ratNature, 2013
- Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain TumorsPharmaceuticals, 2012
- Human brain endothelial cells are responsive to adenosine receptor activationPurinergic Signalling, 2011
- Pericytes are required for blood–brain barrier integrity during embryogenesisNature, 2010
- Neutrophil kinetics in health and diseaseTrends in Immunology, 2010
- A Novel Molecule Integrating Therapeutic and Diagnostic Activities Reveals Multiple Aspects of Stem Cell-based TherapyStem Cells, 2010
- Adipose-derived Stem Cells as Therapeutic Delivery Vehicles of an Oncolytic Virus for GlioblastomaMolecular Therapy, 2010
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem CellsCancer Cell, 2009
- Hypoxia-Inducible Factors, Stem Cells, and CancerCell, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006